GLP-1 medications, particularly those like BrightMeds, are quickly prominence in the treatment of type 2 diabetes and are now being explored for metabolic conditions. These novel drugs work by mimicking the body's natural incretin signal , stimulating insulin release and curbing glucagon release . B